Chronic Viral and Inflammatory Cardiomyopathy

Chronic Viral and Inflammatory Cardiomyopathy.- Overview on Chronic Viral Cardiomyopathy/Chronic Myocarditis.- Unsolved Medical Issues and New Targets for Further Research in Viral Myocarditis and Dilated Cardiomyopathy.- Viruses.- Frontiers in Viral Diagnostics.- Invited for Debate: Is Virus Persistence a Determinant for Disease Progression?.- Parvovirus B19: The Causative Agent of Dilated Cardiomyopathy or a Harmless Passenger of the Human Myocard?.- Parvovirus B19: A New Emerging Pathogenic Agent of Inflammatory Cardiomyopathy.- Role of Hepatitis C Virus in Cardiomyopathies.- Immunity and Autoimmunity.- Recent Insights into the Role of Host Innate and Acquired Immunity Responses.- The Significance of Autoimmunity in Myocarditis.- The Roles of Immunity and Autoimmunity in Chronic Heart Failure.- Clinical Implications of Anti-cardiac Immunity in Dilated Cardiomyopathy.- Cardiac Remodeling.- Inflammation and Cardiac Remodeling During Viral Myocarditis.- Inflammatory Cardiomyopathy: There Is a Specific Matrix Destruction in the Course of the Disease.- Invited for Debate: Is There a Virus-Specific Matrix Destruction in the Course of Disease in Dilated Cardiomyopathy?.- Diagnosis and Treatment.- New Non-invasive Approaches for the Diagnosis of Cardiomyopathy: Magnetic Resonance Imaging.- New Therapeutics Targets in Chronic Viral Cardiomyopathy.- Myocarditis and Inflammatory Cardiomyopathy: Histomorphological Diagnosis.- Anti-viral Treatment in Patients with Virus-Induced Cardiomyopathy.- Immunosuppressive Treatment of Chronic Non-viral Myocarditis.- Immunoadsorption in Dilated Cardiomyopathy.